Roswell Park Cancer Institute has been awarded a nearly $12 million state grant for stem cell research.
The $11.9 million award will go toward a project to "re-engineer adult stem cells derived from blood to target ovarian cancer. By infusing these re-engineered cells into cancer patients, doctors hope to trigger the patients’ immune systems to develop a continuous source of anti-cancer immune cells that will provide sustained attack against ovarian cancer."
The award was one of three grants announced by Governor Cuomo via the New York State Stem Cell Science Program.